The global Roxithromycin API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Roxithromycin(CAS锛�80214-83-1) is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Roxithromycin API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Roxithromycin API market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Roxithromycin API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Roxithromycin API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Roxithromycin API market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Roxithromycin API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Roxithromycin API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Otto Brandes, Beijing Mesochem Technology, Century Pharmaceuticals, Octavius Pharma Pvt. Ltd, HEC Pharm, Kopran, Alembic Pharmaceuticals Limited, Envee Drugs, Zhejiang Zhenyuan Pharmaceutical, Huangshi Shixing Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Roxithromycin API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Above 98 %
Above 99 %
Market segment by Application
Tablets
Capsules
Granules
Others
Major players covered
Otto Brandes
Beijing Mesochem Technology
Century Pharmaceuticals
Octavius Pharma Pvt. Ltd
HEC Pharm
Kopran
Alembic Pharmaceuticals Limited
Envee Drugs
Zhejiang Zhenyuan Pharmaceutical
Huangshi Shixing Pharmaceutical
Hanways Chempharm Co., Limited
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Roxithromycin API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Roxithromycin API, with price, sales quantity, revenue, and global market share of Roxithromycin API from 2020 to 2025.
Chapter 3, the Roxithromycin API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Roxithromycin API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Roxithromycin API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Roxithromycin API.
Chapter 14 and 15, to describe Roxithromycin API sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Roxithromycin API Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Above 98 %
1.3.3 Above 99 %
1.4 Market Analysis by Application
1.4.1 Overview: Global Roxithromycin API Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Tablets
1.4.3 Capsules
1.4.4 Granules
1.4.5 Others
1.5 Global Roxithromycin API Market Size & Forecast
1.5.1 Global Roxithromycin API Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Roxithromycin API Sales Quantity (2020-2031)
1.5.3 Global Roxithromycin API Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Otto Brandes
2.1.1 Otto Brandes Details
2.1.2 Otto Brandes Major Business
2.1.3 Otto Brandes Roxithromycin API Product and Services
2.1.4 Otto Brandes Roxithromycin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Otto Brandes Recent Developments/Updates
2.2 Beijing Mesochem Technology
2.2.1 Beijing Mesochem Technology Details
2.2.2 Beijing Mesochem Technology Major Business
2.2.3 Beijing Mesochem Technology Roxithromycin API Product and Services
2.2.4 Beijing Mesochem Technology Roxithromycin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Beijing Mesochem Technology Recent Developments/Updates
2.3 Century Pharmaceuticals
2.3.1 Century Pharmaceuticals Details
2.3.2 Century Pharmaceuticals Major Business
2.3.3 Century Pharmaceuticals Roxithromycin API Product and Services
2.3.4 Century Pharmaceuticals Roxithromycin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Century Pharmaceuticals Recent Developments/Updates
2.4 Octavius Pharma Pvt. Ltd
2.4.1 Octavius Pharma Pvt. Ltd Details
2.4.2 Octavius Pharma Pvt. Ltd Major Business
2.4.3 Octavius Pharma Pvt. Ltd Roxithromycin API Product and Services
2.4.4 Octavius Pharma Pvt. Ltd Roxithromycin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Octavius Pharma Pvt. Ltd Recent Developments/Updates
2.5 HEC Pharm
2.5.1 HEC Pharm Details
2.5.2 HEC Pharm Major Business
2.5.3 HEC Pharm Roxithromycin API Product and Services
2.5.4 HEC Pharm Roxithromycin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 HEC Pharm Recent Developments/Updates
2.6 Kopran
2.6.1 Kopran Details
2.6.2 Kopran Major Business
2.6.3 Kopran Roxithromycin API Product and Services
2.6.4 Kopran Roxithromycin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Kopran Recent Developments/Updates
2.7 Alembic Pharmaceuticals Limited
2.7.1 Alembic Pharmaceuticals Limited Details
2.7.2 Alembic Pharmaceuticals Limited Major Business
2.7.3 Alembic Pharmaceuticals Limited Roxithromycin API Product and Services
2.7.4 Alembic Pharmaceuticals Limited Roxithromycin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Alembic Pharmaceuticals Limited Recent Developments/Updates
2.8 Envee Drugs
2.8.1 Envee Drugs Details
2.8.2 Envee Drugs Major Business
2.8.3 Envee Drugs Roxithromycin API Product and Services
2.8.4 Envee Drugs Roxithromycin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Envee Drugs Recent Developments/Updates
2.9 Zhejiang Zhenyuan Pharmaceutical
2.9.1 Zhejiang Zhenyuan Pharmaceutical Details
2.9.2 Zhejiang Zhenyuan Pharmaceutical Major Business
2.9.3 Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Product and Services
2.9.4 Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Zhejiang Zhenyuan Pharmaceutical Recent Developments/Updates
2.10 Huangshi Shixing Pharmaceutical
2.10.1 Huangshi Shixing Pharmaceutical Details
2.10.2 Huangshi Shixing Pharmaceutical Major Business
2.10.3 Huangshi Shixing Pharmaceutical Roxithromycin API Product and Services
2.10.4 Huangshi Shixing Pharmaceutical Roxithromycin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Huangshi Shixing Pharmaceutical Recent Developments/Updates
2.11 Hanways Chempharm Co., Limited
2.11.1 Hanways Chempharm Co., Limited Details
2.11.2 Hanways Chempharm Co., Limited Major Business
2.11.3 Hanways Chempharm Co., Limited Roxithromycin API Product and Services
2.11.4 Hanways Chempharm Co., Limited Roxithromycin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hanways Chempharm Co., Limited Recent Developments/Updates
3 Competitive Environment: Roxithromycin API by Manufacturer
3.1 Global Roxithromycin API Sales Quantity by Manufacturer (2020-2025)
3.2 Global Roxithromycin API Revenue by Manufacturer (2020-2025)
3.3 Global Roxithromycin API Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Roxithromycin API by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Roxithromycin API Manufacturer Market Share in 2024
3.4.3 Top 6 Roxithromycin API Manufacturer Market Share in 2024
3.5 Roxithromycin API Market: Overall Company Footprint Analysis
3.5.1 Roxithromycin API Market: Region Footprint
3.5.2 Roxithromycin API Market: Company Product Type Footprint
3.5.3 Roxithromycin API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Roxithromycin API Market Size by Region
4.1.1 Global Roxithromycin API Sales Quantity by Region (2020-2031)
4.1.2 Global Roxithromycin API Consumption Value by Region (2020-2031)
4.1.3 Global Roxithromycin API Average Price by Region (2020-2031)
4.2 North America Roxithromycin API Consumption Value (2020-2031)
4.3 Europe Roxithromycin API Consumption Value (2020-2031)
4.4 Asia-Pacific Roxithromycin API Consumption Value (2020-2031)
4.5 South America Roxithromycin API Consumption Value (2020-2031)
4.6 Middle East & Africa Roxithromycin API Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Roxithromycin API Sales Quantity by Type (2020-2031)
5.2 Global Roxithromycin API Consumption Value by Type (2020-2031)
5.3 Global Roxithromycin API Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Roxithromycin API Sales Quantity by Application (2020-2031)
6.2 Global Roxithromycin API Consumption Value by Application (2020-2031)
6.3 Global Roxithromycin API Average Price by Application (2020-2031)
7 North America
7.1 North America Roxithromycin API Sales Quantity by Type (2020-2031)
7.2 North America Roxithromycin API Sales Quantity by Application (2020-2031)
7.3 North America Roxithromycin API Market Size by Country
7.3.1 North America Roxithromycin API Sales Quantity by Country (2020-2031)
7.3.2 North America Roxithromycin API Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Roxithromycin API Sales Quantity by Type (2020-2031)
8.2 Europe Roxithromycin API Sales Quantity by Application (2020-2031)
8.3 Europe Roxithromycin API Market Size by Country
8.3.1 Europe Roxithromycin API Sales Quantity by Country (2020-2031)
8.3.2 Europe Roxithromycin API Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Roxithromycin API Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Roxithromycin API Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Roxithromycin API Market Size by Region
9.3.1 Asia-Pacific Roxithromycin API Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Roxithromycin API Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Roxithromycin API Sales Quantity by Type (2020-2031)
10.2 South America Roxithromycin API Sales Quantity by Application (2020-2031)
10.3 South America Roxithromycin API Market Size by Country
10.3.1 South America Roxithromycin API Sales Quantity by Country (2020-2031)
10.3.2 South America Roxithromycin API Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Roxithromycin API Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Roxithromycin API Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Roxithromycin API Market Size by Country
11.3.1 Middle East & Africa Roxithromycin API Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Roxithromycin API Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Roxithromycin API Market Drivers
12.2 Roxithromycin API Market Restraints
12.3 Roxithromycin API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Roxithromycin API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Roxithromycin API
13.3 Roxithromycin API Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Roxithromycin API Typical Distributors
14.3 Roxithromycin API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Otto Brandes
Beijing Mesochem Technology
Century Pharmaceuticals
Octavius Pharma Pvt. Ltd
HEC Pharm
Kopran
Alembic Pharmaceuticals Limited
Envee Drugs
Zhejiang Zhenyuan Pharmaceutical
Huangshi Shixing Pharmaceutical
Hanways Chempharm Co., Limited
听
听
*If Applicable.
